Renalytix plc (RENX) ORD GBP0.0025

- Add to watchlist
- Create an alert
- This stock can be held in a




7.75p
8.50p
12.50p
£24.18 million
7.75p
6.50p
5.75p
n/a
1.23p (13.70%) Previous:
1.23p
31,223,528
n/a
20,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/06/2024 | 30/06/2023 |
---|---|---|
Revenue ($m) | 2.29 | 3.40 |
Profit before tax ($m) | (33.45) | (45.60) |
Adjusted EPS (p): | (31.00) | (55.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Renalytix shares more than double after striking US diagnostics partnership
15 September 2025 09:25
-
Renalytix enters new collaboration with NYKHM
3 June 2025 14:17
-
Renalytix Q3 revenues up 20pc
10 April 2025 11:41
-
Holding(s) in Company
17 September 2025 07:00
-
Holding(s) in Company
16 September 2025 18:26
-
Holding(s) in Company
16 September 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.